Evaluating of the effectiveness and safety of the reproduced selective b1-blocker without intrinsic sympathomimetic activity Bidop® in patients with hypertrophic cardiomyopathy

Системные гипертензии

Feiskhanova L.I.¹  Malov A.A.¹ 

[1] Kazan State Medical University of the Ministry of Health of the Russian Federation. 420012, Russian Federation, Kazan, ul. Butlerova, d. 49;

关键词: b-blockers;    bisoprolol;    Bidop;    hypertrophic cardiomyopathy;   

DOI  :  10.26442/2075-082X_13.2.88-90

来源: DOAJ

【 摘 要 】

The article assesses the effectiveness of therapy generics Bidop® production of Gеdeon Richter (Hungary), designated to improve diastolic function, and treatment of heart failureof patients with hypertrophic cardiomyopathy with predominant hypertrophy of the interventricular septum and symmetrical concentric shape in the absence of obstruction of outflow tract of the left ventricle (LV). The effect of the presence of zones of intramyocardial fibrosis hypertrophied LV departments identified through MRI delayed contrast, to the process of active relaxation.

【 授权许可】

Unknown